Engineering Actinomycetes for Biosynthesis of Macrolactone Polyketides

Overview

Journal Microb Cell Fact

Publisher Biomed Central

Specialties Biotechnology
Microbiology

Date 2019 Aug 15

PMID 31409353

Citations 12

Authors

Dipesh Dhakal

Jae Kyung Sohng

Ramesh Prasad Pandey

Affiliations

Soon will be listed here.

Abstract

Actinobacteria are characterized as the most prominent producer of natural products (NPs) with pharmaceutical importance. The production of NPs from these actinobacteria is associated with particular biosynthetic gene clusters (BGCs) in these microorganisms. The majority of these BGCs include polyketide synthase (PKS) or non-ribosomal peptide synthase (NRPS) or a combination of both PKS and NRPS. Macrolides compounds contain a core macro-lactone ring (aglycone) decorated with diverse functional groups in their chemical structures. The aglycon is generated by megaenzyme polyketide synthases (PKSs) from diverse acyl-CoA as precursor substrates. Further, post-PKS enzymes are responsible for allocating the structural diversity and functional characteristics for their biological activities. Macrolides are biologically important for their uses in therapeutics as antibiotics, anti-tumor agents, immunosuppressants, anti-parasites and many more. Thus, precise genetic/metabolic engineering of actinobacteria along with the application of various chemical/biological approaches have made it plausible for production of macrolides in industrial scale or generation of their novel derivatives with more effective biological properties. In this review, we have discussed versatile approaches for generating a wide range of macrolide structures by engineering the PKS and post-PKS cascades at either enzyme or cellular level in actinobacteria species, either the native or heterologous producer strains.

Citing Articles

Post-crotonylation oxidation by a monooxygenase promotes acetyl-CoA synthetase degradation in Streptomyces roseosporus.

Ma B, Sun C, Zhou J, Gu S, Dai X, Chen Y Commun Biol. 2023; 6(1):1243.

PMID: 38066175 PMC: 10709465. DOI: 10.1038/s42003-023-05633-0.

Biosynthesis of Lyngbyastatins 1 and 3, Cytotoxic Depsipeptides from an sp. Marine Cyanobacterium.

Dhakal D, Kokkaliari S, Rubin G, Paul V, Ding Y, Luesch H J Nat Prod. 2022; 86(1):85-93.

PMID: 36546857 PMC: 10197921. DOI: 10.1021/acs.jnatprod.2c00782.

Marine Macrolides to Tackle Antimicrobial Resistance of .

Mamada S, Nainu F, Masyita A, Frediansyah A, Utami R, Salampe M Mar Drugs. 2022; 20(11).

PMID: 36355013 PMC: 9697125. DOI: 10.3390/md20110691.

Polyene Macrolactams from Marine and Terrestrial Sources: Structure, Production Strategies, Biosynthesis and Bioactivities.

Zhao W, Jiang H, Liu X, Zhou J, Wu B Mar Drugs. 2022; 20(6).

PMID: 35736163 PMC: 9230918. DOI: 10.3390/md20060360.

BAC Cloning of a Large-Sized Biosynthetic Gene Cluster of NPP B1, a Potential SARS-CoV-2 RdRp Inhibitor.

Park J, Park H, Nah H, Kang S, Choi S, Kim E J Microbiol Biotechnol. 2022; 32(7):911-917.

PMID: 35719079 PMC: 9628923. DOI: 10.4014/jmb.2205.05036.

References

Jung W, Kim E, Yoo Y, Ban Y, Kim E, Yoon Y . Characterization and engineering of the ethylmalonyl-CoA pathway towards the improved heterologous production of polyketides in Streptomyces venezuelae. Appl Microbiol Biotechnol. 2014; 98(8):3701-13. DOI: 10.1007/s00253-013-5503-8. View

DEMAIN A, Elander R . The beta-lactam antibiotics: past, present, and future. Antonie Van Leeuwenhoek. 1999; 75(1-2):5-19. DOI: 10.1023/a:1001738823146. View

Zhang X, Li S . Expansion of chemical space for natural products by uncommon P450 reactions. Nat Prod Rep. 2017; 34(9):1061-1089. DOI: 10.1039/c7np00028f. View

Zhang W, Tang Y . Combinatorial biosynthesis of natural products. J Med Chem. 2008; 51(9):2629-33. DOI: 10.1021/jm701269v. View

Baltz R, Seno E, Stonesifer J, WILD G . Biosynthesis of the macrolide antibiotic tylosin. A preferred pathway from tylactone to tylosin. J Antibiot (Tokyo). 1983; 36(2):131-41. DOI: 10.7164/antibiotics.36.131. View

Dhakal D, Pokhrel A, Shrestha B, Sohng J . Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds. Front Microbiol. 2017; 8:1106. PMC: 5471306. DOI: 10.3389/fmicb.2017.01106. View

Sanchez C, Salas A, Brana A, Palomino M, Pineda-Lucena A, Carbajo R . Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles. Chem Commun (Camb). 2009; (27):4118-20. DOI: 10.1039/b905068j. View

Genilloud O . Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?. Antibiotics (Basel). 2018; 7(4). PMC: 6316141. DOI: 10.3390/antibiotics7040085. View

Sundermann U, Bravo-Rodriguez K, Klopries S, Kushnir S, Gomez H, Sanchez-Garcia E . Enzyme-directed mutasynthesis: a combined experimental and theoretical approach to substrate recognition of a polyketide synthase. ACS Chem Biol. 2012; 8(2):443-50. DOI: 10.1021/cb300505w. View

10.

Kinoshita K, Pfeifer B, Khosla C, Cane D . Precursor-Directed polyketide biosynthesis in Escherichia coli. Bioorg Med Chem Lett. 2003; 13(21):3701-4. DOI: 10.1016/j.bmcl.2003.08.008. View

11.

Whicher J, Dutta S, Hansen D, Hale W, Chemler J, Dosey A . Structural rearrangements of a polyketide synthase module during its catalytic cycle. Nature. 2014; 510(7506):560-4. PMC: 4074775. DOI: 10.1038/nature13409. View

12.

Wohlleben W, Mast Y, Muth G, Rottgen M, Stegmann E, Weber T . Synthetic biology of secondary metabolite biosynthesis in actinomycetes: Engineering precursor supply as a way to optimize antibiotic production. FEBS Lett. 2012; 586(15):2171-6. DOI: 10.1016/j.febslet.2012.04.025. View

13.

Newman D, Cragg G . Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016; 79(3):629-61. DOI: 10.1021/acs.jnatprod.5b01055. View

14.

Osswald C, Zipf G, Schmidt G, Maier J, Bernauer H, Muller R . Modular construction of a functional artificial epothilone polyketide pathway. ACS Synth Biol. 2013; 3(10):759-72. DOI: 10.1021/sb300080t. View

15.

Laureti L, Song L, Huang S, Corre C, Leblond P, Challis G . Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc Natl Acad Sci U S A. 2011; 108(15):6258-63. PMC: 3076887. DOI: 10.1073/pnas.1019077108. View

16.

Weber J, Cernota W, Gonzalez M, Leach B, Reeves A, Wesley R . An erythromycin process improvement using the diethyl methylmalonate-responsive (Dmr) phenotype of the Saccharopolyspora erythraea mutB strain. Appl Microbiol Biotechnol. 2011; 93(4):1575-83. PMC: 3276693. DOI: 10.1007/s00253-011-3650-3. View

17.

Hans M, Hornung A, Dziarnowski A, Cane D, Khosla C . Mechanistic analysis of acyl transferase domain exchange in polyketide synthase modules. J Am Chem Soc. 2003; 125(18):5366-74. DOI: 10.1021/ja029539i. View

18.

Dhakal D, Chaudhary A, Yi J, Pokhrel A, Shrestha B, Parajuli P . Enhanced production of nargenicin A1 and creation of a novel derivative using a synthetic biology platform. Appl Microbiol Biotechnol. 2016; 100(23):9917-9931. DOI: 10.1007/s00253-016-7705-3. View

19.

Menzella H, Reeves C . Combinatorial biosynthesis for drug development. Curr Opin Microbiol. 2007; 10(3):238-45. DOI: 10.1016/j.mib.2007.05.005. View

20.

Useglio M, Peiru S, Rodriguez E, Labadie G, Carney J, Gramajo H . TDP-L-megosamine biosynthesis pathway elucidation and megalomicin a production in Escherichia coli. Appl Environ Microbiol. 2010; 76(12):3869-77. PMC: 2893496. DOI: 10.1128/AEM.03083-09. View